A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial

Peer Review reports

Original Submission
5 Mar 2021	Submitted	Original manuscript
9 Mar 2021	Reviewed	Reviewer Report - Kirsty Loudon
Resubmission - Version 2
	Submitted	Manuscript version 2
Publishing
10 Mar 2021	Editorially accepted
13 Apr 2021	Article published	10.1186/s13063-021-05180-1

Back to article page